A Study of Nimotuzumab Plus Adebrelimab With Chemotherapy in Cisplatin-Ineligible Patients With Head And Neck Squamous Cell Carcinoma
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Head and Neck Squamous Cell Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Fudan University, Shanghai, Shanghai Municipality, China
Contact: Principal Investigator (Dongmei Ji, doctor)
Study leads
Dongmei Ji, doctor
Principal Investigator
Fudan University